Skip to main content
Figure 1 | BMC Nephrology

Figure 1

From: Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis

Figure 1

Study design and disposition of subjects. A total of 112 patients were enrolled in this study. Questionnaires were administered and blood biochemistry and blood gas were assessed at 0 (baseline), 4, 8, and 12 weeks after the switch in the switch group. In the control group, questionnaires were administered at 0 and 12 weeks, and blood biochemistry assessed at 0, 4, 8, and 12 weeks. Blood gas analysis was not performed in the control group.

Back to article page